A detailed history of Nea Management Company, LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 7,692,298 shares of GLUE stock, worth $54.2 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares
7,692,298
Previous 7,692,298 -0.0%
Holding current value
$54.2 Million
Previous $28.8 Million 41.71%
% of portfolio
3.11%
Previous 2.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$6.71 - $9.72 $73,185 - $106,016
-10,907 Reduced 0.14%
7,692,298 $58.5 Million
Q2 2021

Aug 02, 2021

BUY
$18.86 - $22.7 $145 Million - $175 Million
7,703,205 New
7,703,205 $175 Million

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $329M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.